Better ways to assess kidney recovery and patient experience after acute kidney injury
Compares kidney function tests and gathers experiences of adults after acute kidney injury.
Plain-language title generated from the registry record
Registry title: Improving Patient Assessment After Acute Kidney Injury (AKI)
Key facts
- Where
- Derby, United KingdomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07569588, who can take part
Where in United Kingdom
- University Hospitals of Derby and Burton NHS Foundation TrustDerby, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Nottingham
- Trial code
- NCT07569588
- Record updated
- 6 May 2026
- Original description
The goal of this clinical trial is to improve patient care after acute kidney injury (AKI). It has three related parts. The main questions it aims to answer are:Read full original descriptionShow less
Improving Patient Assessment After Acute Kidney Injury (AKI)
The goal of this clinical trial is to improve patient care after acute kidney injury (AKI). It has three related parts. The main questions it aims to answer are:
1. Is creatinine or cystatin a more reliable assessment of kidney function after AKI? 2. What are the experiences of patients after AKI? 3. What interventions should be recommended to improve assessment and support of patients after AKI?
Participants will be asked to do one or more of:
* blood tests to measure kidney function in different ways * have measurement of their body composition * complete questionnaires about their symptoms * have an interview with a researcher about their experiences * discussion to develop an action plan based on findings
Inclusion: Observational study workstream; Age 18-85 years; AKI stage 2 or 3 during hospital admission OR AKI stage 1 of at least 7 days duration during hospital admission; 60-90 days after peak creatinine Qualitative interview workstream; Age 18-85 years; AKI during hospital admission; 60-90 days after peak creatinine Participatory workshop workstream; Age 18-85 years; Relevant experience (as assessed by the investigator) which could include personal experience of an episode of hospitalised AKI as a patient of carer, experience of managing AKI or related problems in a professional capacity or knowledge of a particular community.
Exclusion: Current treatment with dialysis; Renal transplant; Previous amputation; Current treatment with dialysis; Renal transplant; Receiving palliative care Participatory workshop workstream; Allergy to Omnipaque contrast agent (WP1 only); No baseline creatinine available in previous 12 months; No baseline creatinine available in previous 12 months; Observational study workstream; Inability to give informed consent; Pregnancy or breastfeeding; Pacemaker in situ; Manifest thyrotoxicosis (WP1 only); Ascites or significant (grade 3 to 4) peripheral oedema, defined as ≥6 mm pit, lasting for >1 minute after 5-second compression over tibia or medial malleolus (WP1 only) Qualitative interview workstream; Inability to give informed consent; Inability to give informed consent; Inability to communicate in English (the qualitative workshops will be held in English).